Skip to content

The Effects of Sedentarism on Vascular Function, Inflammation, and Insulin Resistance

The Effects of Sedentarism on Vascular Function, Inflammation, and Insulin Resistance

Status
Terminated
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01412216
Acronym
Bedrest
Enrollment
5
Registered
2011-08-09
Start date
2011-09-30
Completion date
2013-11-30
Last updated
2013-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endothelial Dysfunction, Insulin Resistance, Metabolic Syndrome, Peripheral Arterial Disease

Keywords

Sedentarism, Physical inactivity, Fish oil, Omega-3 fatty acids, Endothelial dysfunction, Insulin resistance, Metabolic syndrome, peripheral arterial disease

Brief summary

The purpose of this study are twofold: 1. To understand the effects of physical inactivity (sedentarism) on vascular function, insulin resistance and inflammation; 2. To assess the role of a dietary intervention (fish oil) in counteracting the effects of physical inactivity on vascular function and inflammation.

Interventions

DIETARY_SUPPLEMENTFish Oil (Omega-3 Fatty Acids)

fish oil-4.4gm/day x 5 days

Sponsors

University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy subjects: Subjects must be free from any acute, chronic or debilitating medical conditions. Healthy status will be established on the basis of clinical history, electrocardiogram, clinical biochemical screening tests of blood and urine, a physical examination, and where necessary a chest radiograph.

Exclusion criteria

* Any active acute or chronic medical problem: Any subject with symptoms of active illness (e.g., fever, leukocytosis, hypertension) will be excluded from study. The

Design outcomes

Primary

MeasureTime frameDescription
Endothelial Function5 daysFlow-mediated, brachial artery vasodilation (FMD)

Secondary

MeasureTime frameDescription
Insulin Resistance5 daysThe homeostatic model assessment (HOMA) method used to quantify insulin resistance (HOMA-IR)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026